跳至主要内容
临床试验/NCT02002026
NCT02002026已完成不适用

Uterine Artery Ligation to Minimize Blood Loss in Patients With Central Placenta Previa

Minia Maternity University Hospital2 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2013年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
52
试验地点
2
主要终点
Changes in hemoglobin level

研究概览

简要总结

This trial will address the effect of uterine artery ligation during Cesarean section in cases with placenta previa to decrease blood loss.

详细描述

This Study will address the effect of uterine artery ligation prior to fetal delivery during Cesarean section in cases with central placenta previa to guard against postpartum hemorrhage and to minimize blood loss.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 49 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Placenta previa is diagnosed when the lowest placental edge is located within 5 cm of the internal os at ultrasound
  • Symptomatic Placenta previa with at least one episode of bleeding
  • Estimated gestational age within 28 to 40 weeks
  • Maternal age > 18 years
  • Informed consent
  • Social affiliation

排除标准

  • Premature rupture of membranes
  • Severe bleeding.
  • Abnormal fetal heart rates.
  • Pre-eclampsia, chorioamnionitis, severe chronic renal disease.

结局指标

主要结局

Changes in hemoglobin level

时间窗: hemoglobin level will be done baseline and will be repeated 24 hours after delivery

Changes in hemoglobin level before and after CS will reflect the amount of blood loss during operation

次要结局

  • Degree of uterine contractility.(During CS and within 3 hours after CS)

研究者

发起方
Minia Maternity University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmad Sameer Sanad

Assistant Professor

Minia Maternity University Hospital

研究点 (2)

Loading locations...

相似试验